MDAI
Spectral AI
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
MDAI Profile
Spectral Ai, Inc.
A Special Purpose Acquisition Company
Healthcare Technology
11/17/2020
04/06/2021
NASDAQ Stock Exchange
78
12-31
Common stock
2515 McKinney Avenue, Suite 1000, Dallas, Texas 75201
--
Spectral AI, Inc., was incorporated in Delaware on November 17, 2020. The company is an artificial intelligence company focused on predictive medical diagnosis. The company is putting a lot of effort into the development of DeepView System, an in-house developed AI-powered MSI device that has FDA BDD status since 2018. The company's DeepView System uses a proprietary AI algorithm to distinguish completely damaged, partially damaged and invisible healthy human tissue features, providing a "Day One" healing potential assessment in seconds. DeepView's output is specially designed to allow doctors to make more accurate, timely and informed decisions about the treatment of patients' wounds.